1. Audited financial results for the quarter ended 30th June 2023. 2. Appointment of Dr. Achala Danait as an Additional Non-Executive Independent Director of the Company subject to approval of the shareholders with effect from 26th July 2023 for a period of five years. Further, Dr. Achala Danait is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other such authority and not related to any Director. 3. Appointment of M/s. D.S. Momaya & Co. LLP, as the Secretarial Auditor of the Company for the financial year 2023- 24. 4. Pursuant to Regulation 30(5) of SEBI Listing Regulations, Managing Director, Chief Financial Officer and Company Secretary & Compliance Officer of the Company are authorised for the purpose of determining the materiality of an event or information and to make disclosure of information to the Stock Exchange(s).